Grey matter abnormalities are associated only with severe cognitive decline in early stages of Parkinson's disease.


Journal

Cortex; a journal devoted to the study of the nervous system and behavior
ISSN: 1973-8102
Titre abrégé: Cortex
Pays: Italy
ID NLM: 0100725

Informations de publication

Date de publication:
02 2020
Historique:
received: 24 09 2018
revised: 11 06 2019
accepted: 26 09 2019
pubmed: 17 11 2019
medline: 27 5 2021
entrez: 17 11 2019
Statut: ppublish

Résumé

Cognitive impairment is common in Parkinson's disease (PD), yet with large heterogeneity in the range and course of deficits. In a cross-sectional study, 124 PD patients underwent extensive clinical and neuropsychological assessment as well as a 3T MRI scan of the brain. Our aim was to identify differences in grey matter volume and thickness, as well as cortical folding, across different cognitive profiles as defined through a data-driven exploratory cluster analysis of neuropsychological data. The identified cognitive groups ranged from cognitively intact patients to patients with severe deficits in all cognitive domains, whilst showing comparable levels of motor disability and disease duration. Each group was compared to the cognitively intact PD group using voxel- and vertex-based morphometry. Results revealed widespread age-related grey matter abnormalities associated with progressive worsening of cognitive functions in mild PD. When adjusted for age, significant differences were only seen between cognitively intact and severely affected PD patients and these were restricted to the right posterior cingulate and the right precuneus. Reduced cortical thickness was seen in the right inferior temporal gyrus and reduced folding in the right temporal region. As these differences were not associated with age, we assume that they are associated with underlying pathology of the cognitive decline. Given the limited involvement of grey matter differences, and the absence of differences in vascular changes across the groups, we hypothesize a more important role for white matter tract changes in cognitive decline in PD.

Identifiants

pubmed: 31733342
pii: S0010-9452(19)30337-5
doi: 10.1016/j.cortex.2019.09.015
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-11

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Amée F Wolters (AF)

Department of Neurology, Maastricht University Medical Center, Maastricht, the Netherlands; School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands.

Anja J H Moonen (AJH)

School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Psychiatry and Neuropsychology, Maastricht University Medical Center, Maastricht, the Netherlands.

Renaud Lopes (R)

Univ. Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France; Inserm, U1171, Lille, France; CHU Lille, Neuroimaging Department, Lille, France.

Albert F G Leentjens (AFG)

School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Psychiatry and Neuropsychology, Maastricht University Medical Center, Maastricht, the Netherlands. Electronic address: a.leentjens@maastrichtuniversity.nl.

Annelien A Duits (AA)

School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Psychiatry and Neuropsychology, Maastricht University Medical Center, Maastricht, the Netherlands.

Luc Defebvre (L)

Univ. Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France; Inserm, U1171, Lille, France; CHU Lille, Neurology and Movement Disorders, Lille, France.

Christine Delmaire (C)

Univ. Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France; Inserm, U1171, Lille, France; CHU Lille, Neuroimaging Department, Lille, France.

Paul A Hofman (PA)

School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Radiology, Maastricht University Medical Center, Maastricht, the Netherlands.

Frank C van Bussel (FC)

School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Radiology, Maastricht University Medical Center, Maastricht, the Netherlands.

Kathy Dujardin (K)

Univ. Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France; Inserm, U1171, Lille, France; CHU Lille, Neurology and Movement Disorders, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH